Corpus Intelligence IC Memo — BROWN COUNTY HOSPITAL 2026-04-26 14:11 UTC
IC Memo — BROWN COUNTY HOSPITAL
Investment Committee Memorandum | NE | 23 beds | Grade D | EBITDA uplift $761K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BROWN COUNTY HOSPITAL

CCN 281325 | BROWN, NE | 23 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BROWN COUNTY HOSPITAL is a 23-bed rural/critical access in BROWN, NE with $10.3M in net patient revenue and a -12.6% operating margin. The hospital serves a payer mix of 80.1% Medicare, 0.7% Medicaid, and 19.2% commercial.

Thesis: Turnaround. Our ML models identify $761K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.6% to -5.2% (+742bps).

Net Revenue HCRIS$10.3M
Current EBITDA COMPUTED$-1.3M
Operating Margin COMPUTED-12.6%
Occupancy HCRIS6.5%
Revenue / Bed COMPUTED$446K
Net-to-Gross HCRIS82.8%
Distress Probability ML65.8%

2. Market Context & Competitive Position

98
NE Hospitals
-6.3%
State Median Margin
65
Comparable Hospitals

NE has 98 Medicare-certified hospitals with a median operating margin of -6.3%. The target's margin of -12.6% places it below the state median. Among 65 size-comparable peers (12-46 beds), the median margin is -4.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 65 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BROWN COUNTY HOSPITAL (Target)NE23$10.3M-12.6%
NEBRASKA ORTHOPAEDIC HOSPITAL NE24$112.1M22.5%
BEATRICE COMMUNITY HOSPITALNE25$84.6M-1.2%
LINCOLN SURGICAL HOSPITALNE20$80.9M18.8%
MIDWEST SURGICAL HOSPITALNE19$70.1M36.2%
PHELPS MEMORIAL HEALTH CENTERNE25$69.0M8.2%
SIDNEY REGIONAL MEDICAL CENTERNE19$68.0M0.8%
COMMUNITY HOSPITAL ASSOCOCIATINE25$56.0M-7.4%
NEBRASKA SPINE HOSPITALNE34$55.9M49.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $761K (742bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$216K+210bp18mo
Denial Rate Reduction12.0%6.5%$206K+201bp12mo
Cost to Collect4.5%2.5%$205K+200bp12mo
A/R Days Reduction5200.0%3800.0%$125K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$216K
Denial Rate Reduction
$206K
Cost to Collect
$205K
A/R Days Reduction
$125K
Clean Claim Rate
$10K
Total EBITDA Uplift$761K
Current EBITDA$-1.3M
+ RCM Uplift+$761K
Pro Forma EBITDA$-533K
Current Margin-12.6%
Pro Forma Margin-5.2%
WC Released (1x)$394K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.0M$-921K0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.0M$-1.7M0.00x-100.0%
Bull Case9.0x11.0x$-1.8M$206K0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.8M$-304K0.00x-100.0%
Bear Case11.0x10.0x$-2.2M$-4.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.2M$-5.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 80.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 6.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 65.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 65 hospitals with 12-46 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-13.0% / P50=-4.8% / P75=0.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.